Frontiers in Addiction Research and Pregnancy
成瘾研究和怀孕的前沿
基本信息
- 批准号:10359163
- 负责人:
- 金额:$ 36.15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-04-01 至 2023-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdoptedAffectAfrican American populationAlcohol abuseAnimalsAttentionBehavioral ResearchBiomedical ResearchBirthChildClinicalClinical ResearchCollaborationsColorCommunitiesDevelopment PlansDoctor of PhilosophyEducationEducational workshopElderlyEnsureEnvironmental Risk FactorEvaluationFacultyFamilyFosteringFundingFutureGoalsGrantGrowthHealth ProfessionalHispanic AmericansHispanic-serving InstitutionHistorically Black Colleges and UniversitiesIndividualInstitutionInstructionInvestmentsLaboratoriesLaboratory ResearchLearningMainstreamingMedicalMedical StudentsMentorsMethodsMinority-Serving InstitutionModelingMorehouse School of MedicineNational Institute of Drug AbuseNeonatal Abstinence SyndromeOutcomeParticipantPediatricsPharmaceutical PreparationsPhysiciansPostdoctoral FellowPregnancyPregnant WomenPsychologistPublishingQuantitative EvaluationsRecommendationReproducibilityResearchResearch PersonnelResearch TrainingResourcesScientistSelf AdministrationSeriesSexually Transmitted DiseasesStudy SectionSubstance abuse problemTrainingTraining and EducationUnderrepresented MinorityUnited States National Institutes of HealthUniversitiesVulnerable PopulationsWomanWomen&aposs Healthaddictionbasecareercareer developmentcost effectivedesigndrug withdrawaleducation researchethical legal social implicationfrontiergraduate studenthealth disparityhuman subjectimprovedinnovationlecturesmemberminority communitiesminority scientistminority traineeneonatepeerpeople of colorpregnantprogramsrecruitresponsible research conductskill acquisitionskillsteaching assistanttobacco abusetooltranslational approach
项目摘要
PROGRAM SUMMARY/ABSTRACT
This revised application entitled `Frontiers in Addiction Research and Pregnancy [FrARP]' requests R25
funding within NIDA's Research Education Program, responsive to PAR-16-224. FrARP recruits, educates and
helps launch the careers of clinical researchers and clinicians, primarily under-represented minorities (URMs),
starting with an advanced lab course for skills development followed with mentored research, career
mentoring, tracking and evaluations. The course has formal and individual career development components
ensuring that each participant is well versed in vital skills for designing, conducting, and publishing
independent research, obtaining grants, and launching and sustaining independent careers. The target
audience is graduate and medical students, postdoctoral fellows, and early stage scientists and clinicians. The
courses are offered exclusively at URM institutions: Morehouse School of Medicine (a historically Black
Institution) in 2018, 2020, and 2022, and San Diego State University (a Hispanic Serving Institution) in 2019
and 2021. In addition to recruiting URM scientists, FrARP concentrates on a uniquely vulnerable population—
pregnant women who abuse substances and their babies with neonatal abstinence syndrome. These medical
challenges are serious, growing issues for families and for our Nation. Justifications include: the growth of
addiction research; clinical challenges resulting from addiction during pregnancy; and the paucity of labs led by
URM scientists. FrARP's Executive Committee includes Program Director Gerald Schatten, PhD, at Pitt and
Co-PD Michael Kuhar, PhD, at Emory (Addiction Research Leader), together with Co-Is Steve Caritis, MD, at
Pitt (Addiction Obstetrician), Thereasa Cronan, PhD, at SDSU (Facilitator, Psychologist, URM and Women's
Health), Calvin Simerly, PhD, at Pitt (Course Implementer), Evan Snyder, MD, PhD, at SBP (Addiction
Neonatologist), and Winston Thompson, PhD, at MSM (Facilitator, URM and Women's Health). It is overseen
by a Scientific Advisory Board. Related courses have been successful in attracting URMs (31% African-
Americans; 29% Hispanic Americans; 65% women; 51% from URM institutions). Five Specific Aims are
proposed. I. FrARP Advanced Lab Course for skills development provides conceptual education and
research training; II. Mentored Addiction Research; III. Career Planning Tools; IV. Responsible Research
Conduct; and V. Unbiased Quantitative Evaluations to ensure that this R25 is a wise, cost-effective
investment. The R25's goals, then, are to provide courses in skills development, mentored addiction research,
and ongoing career support resulting in comprehensive, sophisticated training in clinical and translational
strategies for addressing the current challenges in addiction during pregnancy, for designing better therapies
for the future, and for launching and sustaining successful careers in substance abuse, pregnancy, pediatrics
and related fields. In so doing, FrARP will help to advance the careers of the most promising clinical scientists
and clinicians, with sensitivity for ensuring full diversity in the NIDA workforce.
项目概要/摘要
这份题为“成瘾研究和怀孕前沿 [FrARP]”的修订申请要求 R25
NIDA 的研究教育计划中的资金,响应 PAR-16-224 的招募、教育和培训。
帮助临床研究人员和信徒(主要是代表性不足的少数群体(URM))开启职业生涯,
从技能发展的高级实验室课程开始,然后是指导研究、职业生涯
该课程包含正式和个人职业发展部分。
确保每个参与者都精通设计、指挥和出版的重要技能
独立研究、获得资助以及开展和维持独立职业目标。
观众是研究生和医学生、博士后研究员以及早期科学家和信徒。
课程仅在 URM 机构提供: 莫尔豪斯医学院(历史悠久的黑人医学院)
机构)(2018 年、2020 年和 2022 年)以及圣地亚哥州立大学(西班牙裔服务机构)2019 年
2021 年。除了招募 URM 科学家外,FrARP 还重点关注独特的弱势群体——
滥用药物的孕妇及其患有新生儿戒断综合症的婴儿。
对于家庭和我们的国家来说,挑战是严峻的、日益严重的问题,理由包括:经济的发展。
成瘾研究;怀孕期间成瘾带来的临床挑战;以及由以下人员领导的实验室的缺乏
URM 的科学家包括皮特大学和皮特大学的项目主任 Gerald Schatten 博士。
埃默里大学的联合PD Michael Kuhar博士(成瘾研究负责人),以及埃默里大学的联合PD Steve Caritis医学博士
Pitt(成瘾产科医生)、SDSU 的 Thereasa Cronan 博士(协调员、心理学家、URM 和妇女)
健康)、Pitt 的 Calvin Simerly 博士(课程实施者)、SBP 的 Evan Snyder 医学博士、博士(成瘾)
新生儿学家)和 MSM 的 Winston Thompson 博士(URM 和妇女健康协调员)。
由科学顾问委员会制定的相关课程已成功吸引了 URM(31% 为非洲人)
美国人;29% 为西班牙裔美国人;65% 为女性;51% 来自 URM 机构)。
I. FrARP 技能发展高级实验室课程提供概念教育和
研究培训;II。
进行;和 V. 公正的定量评估,以确保 R25 是明智的、具有成本效益的
R25 的投资目标是提供技能开发课程、指导成瘾研究、
以及持续的职业支持,从而提供全面、复杂的临床和转化培训
解决当前怀孕期间成瘾挑战的策略,设计更好的疗法
为了未来,为了在药物滥用、怀孕、儿科领域开展和维持成功的职业生涯
FrARP 将帮助推动最有前途的临床科学家的职业生涯。
圣人,具有确保 NIDA 员工队伍充分多样性的敏感性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GERALD SCHATTEN其他文献
GERALD SCHATTEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GERALD SCHATTEN', 18)}}的其他基金
Advancing Native American Diversity in Aging Research through Undergraduate Education (Native American ADAR)
通过本科教育促进美国原住民老龄化研究的多样性(美国原住民 ADAR)
- 批准号:
10460942 - 财政年份:2021
- 资助金额:
$ 36.15万 - 项目类别:
Advancing Native American Diversity in Aging Research through Undergraduate Education (Native American ADAR)
通过本科教育促进美国原住民老龄化研究的多样性(美国原住民 ADAR)
- 批准号:
10172529 - 财政年份:2021
- 资助金额:
$ 36.15万 - 项目类别:
Frontiers in Emerging, Reemerging and Zoonotic Diseases and Diversity (FrERZD2)
新发、再发和人畜共患疾病与多样性前沿 (FrERZD2)
- 批准号:
10666744 - 财政年份:2021
- 资助金额:
$ 36.15万 - 项目类别:
Frontiers in Emerging, Reemerging and Zoonotic Diseases and Diversity (FrERZD2)
新发、再发和人畜共患疾病与多样性前沿 (FrERZD2)
- 批准号:
10313230 - 财政年份:2021
- 资助金额:
$ 36.15万 - 项目类别:
Advancing Native American Diversity in Aging Research through Undergraduate Education (Native American ADAR)
通过本科教育促进美国原住民老龄化研究的多样性(美国原住民 ADAR)
- 批准号:
10619000 - 财政年份:2021
- 资助金额:
$ 36.15万 - 项目类别:
Forefronts in Substance Abuse Disorders during Pregnancy, Postpartum, and Pediatrics (FrSADP3)
妊娠期、产后和儿科药物滥用疾病的前沿 (FrSADP3)
- 批准号:
10741269 - 财政年份:2018
- 资助金额:
$ 36.15万 - 项目类别:
Frontiers in Alzheimer's and Aging Research (FrA2R)
阿尔茨海默病和衰老研究前沿 (FrA2R)
- 批准号:
10441312 - 财政年份:2012
- 资助金额:
$ 36.15万 - 项目类别:
Rehabilitative and Regenerative Medicine for Minority Health & Health Disparities
少数民族健康的康复和再生医学
- 批准号:
8542883 - 财政年份:2012
- 资助金额:
$ 36.15万 - 项目类别:
相似国自然基金
WASP通过影响IL-6R内吞调控Tfh发育和功能
- 批准号:82302055
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
htsA蛋白通过影响碳水化合物摄取抵抗宿主免疫杀伤的机制研究
- 批准号:82302535
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
脱氧胆酸通过c-Abl-YAP通路调控肠粘膜屏障功能对肝脂肪变形成影响
- 批准号:82370558
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
四君子汤通过调节胃粘膜逆生细胞命运影响胃癌前疾病与胃癌发生的作用与机制研究
- 批准号:82373110
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
Piezo1通过PRMT1调节杯状细胞内质网稳态对IBS黏液屏障功能的影响与机制研究
- 批准号:82370548
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
相似海外基金
Implementation of Innovative Treatment for Moral Injury Syndrome: A Hybrid Type 2 Study
道德伤害综合症创新治疗的实施:2 型混合研究
- 批准号:
10752930 - 财政年份:2024
- 资助金额:
$ 36.15万 - 项目类别:
Regulation of human tendon development and regeneration
人体肌腱发育和再生的调节
- 批准号:
10681951 - 财政年份:2023
- 资助金额:
$ 36.15万 - 项目类别:
Implementation and Implications of Sickle Cell Trait Screening in the NCAA
镰状细胞性状筛查在 NCAA 中的实施及其意义
- 批准号:
10842764 - 财政年份:2023
- 资助金额:
$ 36.15万 - 项目类别:
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
- 批准号:
10764456 - 财政年份:2023
- 资助金额:
$ 36.15万 - 项目类别:
Development of a novel visualization, labeling, communication and tracking engine for human anatomy.
开发一种新颖的人体解剖学可视化、标签、通信和跟踪引擎。
- 批准号:
10761060 - 财政年份:2023
- 资助金额:
$ 36.15万 - 项目类别: